UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000029542
Receipt number R000033752
Scientific Title Medical Survey in Japanese-Americans "the Hawaii-Los Angeles-Hiroshima Study"
Date of disclosure of the study information 2017/10/13
Last modified on 2023/04/20 18:54:45

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Medical Survey in Japanese-Americans "the Hawaii-Los Angeles-Hiroshima Study"

Acronym

The Hawaii-Los Angeles-Hiroshima Study

Scientific Title

Medical Survey in Japanese-Americans "the Hawaii-Los Angeles-Hiroshima Study"

Scientific Title:Acronym

The Hawaii-Los Angeles-Hiroshima Study

Region

Japan North America


Condition

Condition

Diabetes, Obesity, Arteriosclerosis

Classification by specialty

Endocrinology and Metabolism

Classification by malignancy

Others

Genomic information

YES


Objectives

Narrative objectives1

Comparison between native Japanese and Japanese-Americans whose lifestyles are different.

Basic objectives2

Others

Basic objectives -Others

Epidemiology

Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

The incidence of obesity and diabetes, the development of arteriosclerosis.

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

none

Key exclusion criteria

none

Target sample size

500


Research contact person

Name of lead principal investigator

1st name Haruya
Middle name
Last name Ohno

Organization

Hiroshima University Hospital

Division name

Endocrinology and Diabetic Medicine

Zip code

734-8551

Address

1-2-3 Kasumi, Minami-ku, Hiroshima, 734-8551

TEL

082-257-5198

Email

haruya-ohno@hiroshima-u.ac.jp


Public contact

Name of contact person

1st name Haruya
Middle name
Last name Ohno

Organization

Hiroshima University Hospital

Division name

Endocrinology and Diabetic Medicine

Zip code

734-8551

Address

1-2-3 Kasumi, Minami-ku, Hiroshima, 734-8551

TEL

082-257-5196

Homepage URL


Email

haruya-ohno@hiroshima-u.ac.jp


Sponsor or person

Institute

Hiroshima University

Institute

Department

Personal name



Funding Source

Organization

Self funding

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Hiroshima University

Address

1-2-3 Kasumi, Minami-ku, Hiroshima, 734-8551

Tel

082-257-5196

Email

iryo-seisaku@office.hiroshima-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2017 Year 10 Month 13 Day


Related information

URL releasing protocol


Publication of results

Partially published


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2002 Year 07 Month 01 Day

Date of IRB

2002 Year 06 Month 10 Day

Anticipated trial start date

2002 Year 07 Month 01 Day

Last follow-up date

2025 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

There are many reports (Pubmed).


Management information

Registered date

2017 Year 10 Month 13 Day

Last modified on

2023 Year 04 Month 20 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000033752


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name